bioRxivBioinformaticsPreprint
Bioinformatics Approach on Hypothetical Protein from Clostridioides difficile: Structural, Functional and Molecular Docking Analysis
Abstract
Clostridioides difficile (C. difficile) has become a globally important pathogen as epidemic strains spread through hospitals in many countries. Despite the advancements in infection therapy, there is a need for more efficacious medicines against C. difficile that simultaneously minimize injury to the resident gut microbiota. The study aims to investigate various aspects of the protein, including its physicochemical properties, subcellular location, functional elucidation, protein-protein interactions, structure prediction, validation, determination of active sites for potential ligands, and MD study. The protein is partially basic and hydrophobic, according to the physicochemical properties analysis. The protein has activities in the inner membrane and the cytoplasm with two transmembrane helices. Furthermore, the protein is involved in secondary transporters in the MFS system, resulting in the movement of various substances through cytoplasmic or internal membranes. We targeted the active sites of the protein as potential binding sites for ligand molecules to discover novel therapeutic agents. The MD study documented the interaction of the selected ligands (PA{beta}N and CCCP) with the protein. PA{beta}N demonstrated the most suitable ligand compared to CCCP, as it required the lowest energy (- 6.7 kcal/mol) to interact with the protein. This functional protein can be targeted for further study on potential therapeutic candidates against the protein of C. difficile.
- organism: C. elegans
- assay: protein structure
- research focus: protein structure prediction
- research focus: drug response / drug discovery
- approach: statistical model
- approach: simulation
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- De novo design of potent inhibitors of Clostridioides difficile toxin B
Robert J. Ragotte, Huazhu Liang, … David A. Baker·Proceedings of the National Academy of SciencesPeer-reviewed·Sep 22, 2025
- Structure of the cell-binding component of the Clostridium difficile binary toxin reveals a novel macromolecular assembly
X. Xu, R. Ruiz, … D. J. Weber·bioRxiv·Nov 10, 2019
- Identification of a bile acid-binding transcription factor in Clostridioides difficile using chemical proteomics
E. R. Forster, X. Yang, … A. Shen·bioRxiv·May 26, 2022
- A Rationally Designed Antimicrobial Peptide from Structural and Functional Insight of Clostridium difficile Translation Initiation Factor 1
E. Alanis, F. Aguilar, … Y. Zhang·bioRxiv·Jun 30, 2023
- The C-terminal domain of Clostridioides difficile TcdC is exposed on the bacterial cell surface
A. M. oliveira paiva, L. de Jong, … J. Corver·bioRxiv·Dec 11, 2019
- Blocking toxin function and modulating the gut microbiota: caffeic acid phenethyl ester as a potential treatment for Clostridioides difficile infection
Yan Guo, Yong Zhang, … Jiazhang Qiu·bioRxiv·Aug 19, 2024